|
|
| Where Formulation Expertise Connects | As pipelines grow more complex and timelines become more ambitious, companies increasingly rely on strong external partners to advance their drug products efficiently and with reduced risk. This is where integrated expertise in formulation development, analytical characterization, and CMC strategy becomes a key enabler for successful partnerships. The BIO International Convention in San Diego is one of the leading global partnering events for the biotech and pharmaceutical industry, bringing together innovators, decision-makers, and service providers to build meaningful collaborations. Learn more. |
|
|
|
| Spray Dried Biologics For Injectable Dosage Forms | White Paper | By Dr. Richard Johnson, Upperton Pharma Solutions | Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods. |
|
|
| Moving Beyond Known Targets | Article | By Jonas Mortensen, BioBridge | A pioneering perspective explores how new scientific thinking, physics‑based insights, and bold leadership are expanding the druggable universe and opening therapeutic paths once thought impossible. |
|
|
| Integrated Drug Discovery: Hit To PCC In 16 Months | Case Study | BioDuro | Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Confirming data is now at hand. In 2005, we suggested Europe’s CDMOs couldn’t wait for a political or trade détente vis-à-vis the U.S. If they actively leveraged their reputation for reliability, tariffs would not meaningfully redirect manufacturing to the U.S. Here's an analysis of a GlobalData report on what has transpired. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| Flow Chemistry For Contemporary Isotope Labeling | Article | By Mounir Raji, X-Chem | Gain insight into how late‑stage exchange and flow‑based methods enable efficient access to labeled molecules for pharmaceuticals, mechanistic studies, and analytical applications. |
|
|
|
| Tracing PS80: How LC‑MS Resolved A Potency Discrepancy | Case Study | By Neil Lloyd, KBI Biopharma | A targeted LC–MS investigation identifies molecular changes behind potency discrepancies, enabling accurate root‑cause analysis and stronger control of monoclonal antibody product quality. |
|
|
| Rapid, Reliable Technology Transfer | Article | WuXi Biologics | See how structured planning, expert coordination, and risk‑focused execution speed tech transfer, improve consistency, and move biologics into manufacturing faster. |
|
|
| Five Tips For A Successful Tech Transfer To A CDMO | Article | 53Biologics | Successful tech transfer depends on solid documentation, early teamwork, clear expectations, proactive risk planning, and experienced partners to keep execution smooth and projects moving on schedule. |
|
|
|
| How To Choose The Right CDMO Partner For Fill & Finish | Article | medac CDMO | CDMO selection requires evaluating experience, quality standards, and flexibility. Assess technical transfer skills, supply chain security, and collaborative approach for a reliable, long-term project fit. |
|
|
| Discussing Qualities Of A CDMO Redefining Innovation | Article | Grand River Aseptic Manufacturing | Ensuring precision in fill/finish for large-volume devices is critical for performance. Discover the essential traits that redefine innovation and support patient-centric manufacturing solutions. |
|
|
| From Tactical Response To Strategic Imperative | White Paper | Thermo Fisher Scientific | Build flexibility into your drug development strategy to navigate change effectively, maintain momentum, and drive successful outcomes across every stage of the lifecycle. |
|
|
|
|
|
|
|
|
| Webinar: Breaking the Titer Ceiling: Smarter Media Design for Higher Productivity | Discover how a bottom-up media development strategy can improve fed-batch bioproduction performance. In this webinar, KBI experts will demonstrate how chemically defined minimalist formulations and Design of Experiments (DOE) approaches help optimize basal and feed media, enhance cell culture productivity, increase titer, and overcome metabolic limitations—all while maintaining critical product quality attributes and process consistency. Click here to learn more. |
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
